Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Calligaro

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
African Journal of Thoracic and Critical Care Medicine|July 9, 2021
Younger, not better: No influence of age on lung cancer stage at diagnosis in South AfricaGreg Calligaro
African Journal of Thoracic and Critical Care Medicine|September 20, 2021
Selecting the right patients is the keyRichard van Zyl-Smit, Greg Calligaro
African Journal of Thoracic and Critical Care Medicine|August 28, 2023
Interstitial lung disease: Does it matter what we call you, or what you look like, or how you behave?Richard van Zyl-Smit, Gurveen Soin, Greg Calligaro
American Journal of Respiratory and Critical Care Medicine|August 7, 2023
Affordable Cystic Fibrosis (CF) Transmembrane Conductance Regulator Modulator Drugs for CF: All CF Lives Worldwide Matter!Marco Zampoli, Janine Verstraete, Cathy Baird, et al.
Pediatric Pulmonology|October 15, 2025
Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and InequalityMarco Zampoli, Cathy Baird, Brenda Morrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Grant Theron, Rouxjeane Venter, Greg Calligaro, et al.
Journal of Clinical Microbiology|January 7, 2018
False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical OutcomesGrant Theron, Rouxjeane Venter, Liezel Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case SeriesIlan S Schwartz, Nelesh P Govender, Craig Corcoran, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 5, 2025
Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce costMarco Zampoli, Janine Verstraete, Cathy Baird, et al.
BMC Pulmonary Medicine|April 9, 2014
Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort studyRichard Meldau, Jonny Peter, Grant Theron, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
African Journal of Thoracic and Critical Care Medicine|July 9, 2021
Younger, not better: No influence of age on lung cancer stage at diagnosis in South AfricaGreg Calligaro
African Journal of Thoracic and Critical Care Medicine|September 20, 2021
Selecting the right patients is the keyRichard van Zyl-Smit, Greg Calligaro
African Journal of Thoracic and Critical Care Medicine|August 28, 2023
Interstitial lung disease: Does it matter what we call you, or what you look like, or how you behave?Richard van Zyl-Smit, Gurveen Soin, Greg Calligaro
American Journal of Respiratory and Critical Care Medicine|August 7, 2023
Affordable Cystic Fibrosis (CF) Transmembrane Conductance Regulator Modulator Drugs for CF: All CF Lives Worldwide Matter!Marco Zampoli, Janine Verstraete, Cathy Baird, et al.
Pediatric Pulmonology|October 15, 2025
Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and InequalityMarco Zampoli, Cathy Baird, Brenda Morrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Grant Theron, Rouxjeane Venter, Greg Calligaro, et al.
Journal of Clinical Microbiology|January 7, 2018
False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical OutcomesGrant Theron, Rouxjeane Venter, Liezel Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case SeriesIlan S Schwartz, Nelesh P Govender, Craig Corcoran, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 5, 2025
Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce costMarco Zampoli, Janine Verstraete, Cathy Baird, et al.
BMC Pulmonary Medicine|April 9, 2014
Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort studyRichard Meldau, Jonny Peter, Grant Theron, et al.
Pageof 2